Newborn affected by noxious substances transmitted via placenta or breast milk - P04
This notation helps users understand the scope of a code P04 category and provides additional information about the conditions or terms that fall under that category.
Category Includes:
- nonteratogenic effects of substances transmitted via placenta
Excludes2: This note means that the conditions described by two codes are not usually associated with each other but can sometimes occur together.
Type 2 Excludes:
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Code First: This note advises that another code should be sequenced as the principal diagnosis before the code with this note.
Category codeFirst:
- any current condition in newborn, if applicable
These ranges represents subcategories of Newborn affected by noxious substances transmitted via placenta or breast milk. The "P04" signifies that these are the diseases within this broad category.
Codes:
- P04.0 - Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
- P04.1 - Newborn affected by other maternal medication
- P04.11 - Newborn affected by maternal antineoplastic chemotherapy
- P04.12 - Newborn affected by maternal cytotoxic drugs
- P04.13 - Newborn affected by maternal use of anticonvulsants
- P04.14 - Newborn affected by maternal use of opiates
- P04.15 - Newborn affected by maternal use of antidepressants
- P04.16 - Newborn affected by maternal use of amphetamines
- P04.17 - Newborn affected by maternal use of sedative-hypnotics
- P04.18 - Newborn affected by other maternal medication
- P04.19 - Newborn affected by maternal use of unspecified medication
- P04.1A - Newborn affected by maternal use of anxiolytics
- P04.2 - Newborn affected by maternal use of tobacco
- P04.3 - Newborn affected by maternal use of alcohol
- P04.4 - Newborn affected by maternal use of drugs of addiction
- P04.40 - Newborn affected by maternal use of unspecified drugs of addiction
- P04.41 - Newborn affected by maternal use of cocaine
- P04.42 - Newborn affected by maternal use of hallucinogens
- P04.49 - Newborn affected by maternal use of other drugs of addiction
- P04.5 - Newborn affected by maternal use of nutritional chemical substances
- P04.6 - Newborn affected by maternal exposure to environmental chemical substances
- P04.8 - Newborn affected by other maternal noxious substances
- P04.81 - Newborn affected by maternal use of cannabis
- P04.89 - Newborn affected by other maternal noxious substances
- P04.9 - Newborn affected by maternal noxious substance, unspecified